The four evidence-based deprescribing guidelines and algorithms produced through the leadership of the Bruyère Research Institute and the Ontario Pharmacy Evidence Network, and the guideline developed through an NHMRC-ARC Dementia Research Fellowship have been built as a series of mobile applications on a “Deprescribing Channel” with the McGill-based IAM Medical Guidelines. This study used the Information Assessment Method for health care provider users to evaluate the usefulness of the five deprescribing guideline topics.
Download the FREE app for iOS and Android here:
If you are having issues accessing the Deprescribing channel through the IAM Medical Guidelines app (the iOS version) you will have to uninstall and reinstall the IAM Medical Guidelines app as well as the Deprescribing channel due to recent updates to the terms and conditions. If you are still having issues please contact our team at firstname.lastname@example.org
Lead: Dr. Barbara Farrell, Bruyère Research Institute
Co-investigators: Dr. Roland Grad, Dr. Emily Reeve
Funder (2018-2019): Centre for Aging and Brain Health Innovation
Farrell B, Grad R, Howell P, Quast T, Reeve E. Deprescribing Guidelines: Value of an Interactive Mobile Application. PRiMER. 2020;4:26. https://doi.org/10.22454/PRiMER.2020.349237https://doi.org/10.22454/PRiMER.2020.349237